Verificando…
Traduzido automaticamente. Doses e advertências: confira o original em inglês. Ler em inglês
Início / Registado na Nigéria / G-ciprox Tablet

G-ciprox Tablet

NAFDAC Reg. No. B4-5832 · Drug

Registered with NAFDAC. Registration activeAs of 31 October 2026 · synced automatically from official sources.
Product
G-ciprox Tablet
Número NAFDAC
B4-5832
Princípio ativo
Ciprofloxacin (Ciprofloxacin Hydrochloride)
Dosagem
500 mg
Forma
Tablet
Manufacturer
Not listed
Applicant (holder)
Guilin Pharmaceuticals Nigeria Limited
Approved
28 Sep 2021
Situação
Inactive View on NAFDAC ↗
Registro válido até
27 Sep 2026
Alertas da OMS
None found
Community reports
None
Times checked
0

About the medicine: Ciprofloxacin: uses, dosage and brands worldwide

What we found

  • G-ciprox Tablet is on the NAFDAC register with an active registration (B4-5832). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use G-ciprox Tablet

O que diz a bula oficial. Se um médico receitou, siga a receita. Se a bula da sua caixa for diferente, vale a da sua caixa.

Para quem é

Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens * Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae Streptococcus (Viridans Group) * Conjunctivitis: Haemophilus influenzae Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae *Efficacy for this organism was studied in fewer than 10 infections.

Como tomar e com que frequência
  • Corneal Ulcers: The recommended dosage regimen
  • For the treatment of corneal ulcers is two drops into the affected eye every 15 minutes for the first six hours and then two drops into the affected eye every 30 minutes for the remainder of the first day
  • On the second day, instill two drops in the affected eye hourly
  • On the third through the fourteenth day, place two drops in the affected eye every four hours
  • Treatment may be continued after 14 days if corneal re-epithelialisation has not occurred
  • Bacterial Conjunctivitis: The recommended dosage regimen
  • For the treatment of bacterial conjunctivitis is one or two drops instilled into the conjunctival sac(s) every two hours while awake for two days and one or two drops every four hours while awake for the next five days
Children
  • The safety and effectiveness of Ciprofloxacin ophthalmic solution 0.3% have been established in all ages
  • Use of Ciprofloxacin ophthalmic solution is supported by evidence from adequate and well controlled studies of Ciprofloxacin ophthalmic solution
  • In adults, children and neonates [ see Clinical Studies ]. …
Older adults

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

While you are taking it

Do not touch dropper tip to any surface, as this may contaminate the solution.

Talk to a doctor first if
  • A history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use
  • A history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin
Medicines it may not mix with

Specific drug interaction studies have not been conducted with ophthalmic ciprofloxacin. However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, enhance the effects of the oral anticoagulant, warfarin, and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.

Warnings

NOT FOR INJECTION INTO THE EYE. Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolone therapy. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial edema, dyspnea, urticaria, and itching. Only a few patients had a history of hypersensitivity reactions. Serious anaphylactic reactions require immediate emergency treatment with epinephrine and other resuscitation measures, including oxygen, intravenous fluids, intravenous antihistamines, corticosteroids, pressor amines and airway management, as clinically indicated. …

Possíveis efeitos colaterais

The most frequently reported drug related adverse reaction was local burning or discomfort. In corneal ulcer studies with frequent administration of the drug, white crystalline precipitates were seen in approximately 17% of patients ( see Precautions ). Other reactions occurring in less than 10% of patients included lid margin crusting, crystals/scales, foreign body sensation, itching, conjunctival hyperemia and a bad taste following instillation. Additional events occurring in less than 1% of patients included corneal staining, keratopathy/keratitis, allergic reactions, lid edema, tearing, photophobia, corneal infiltrates, nausea and decreased vision. …

If you take too much

A topical overdose of ciprofloxacin Ophthalmic Solution may be flushed from the eye(s) with warm tap water.

Se esquecer uma dose

Tome assim que lembrar, a menos que esteja quase na hora da próxima dose. Nesse caso, pule a dose esquecida. Nunca tome duas doses de uma vez para compensar. Confira a bula, pois alguns medicamentos são diferentes.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2022-05-02.

Label for ciprofloxacin (ciprofloxacin hydrochloride), the active ingredient registered with NAFDAC.

Check your pack of G-ciprox Tablet

Add the expiry date on your pack for a full Trust Score.

Ou tire fotos da caixa
Restam 3 verificações grátis hoje Fontes oficiais: FDA dos EUA · EMA (UE) · NAFDAC · alertas da OMS

About G-ciprox Tablet

What is in G-ciprox Tablet?

G-ciprox Tablet contains Ciprofloxacin (Ciprofloxacin Hydrochloride) (500 mg), as tablet, according to its NAFDAC registration record.

Is G-ciprox Tablet registered with NAFDAC?

Yes. G-ciprox Tablet is listed on the NAFDAC register under registration number B4-5832, and its registration is active as of 31 October 2026.

Has G-ciprox Tablet been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches G-ciprox Tablet in our automatically synced alert list.

How can I check that my pack of G-ciprox Tablet is genuine?

Run a free authenticity scan with the NAFDAC number B4-5832, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take G-ciprox Tablet?

Follow your prescription or the leaflet in your pack. The official label says: Corneal Ulcers: The recommended dosage regimen for the treatment of corneal ulcers is two drops into the affected eye every 15 minutes for the first six hours and then two drops into the affected eye every 30 minutes for the remainder of the first day. On the second day, instill two drops in the affected eye hourly. On the third through the fourteenth day, place two drops in th…

What is G-ciprox Tablet used for?

Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens * Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae Streptococcus (Viridans Group) * Conjunctivitis: Haemophilus influenzae Staphylococcus aure (Summarised from the official U.S. FDA label for ciprofloxacin (ciprofloxacin hydrochloride). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used G-ciprox Tablet? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.